Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NovoCure Limited - Ordinary Shares (NQ:NVCR)

15.58 -0.25 (-1.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NovoCure Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
What 11 Analyst Ratings Have To Say About NovoCure
Via Benzinga
PDD Holdings, UP Fintech Holding, Big Lots And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Gains Over 100 Points; Hawaiian Electric Shares Surge
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 34,490.80 while the NASDAQ rose 0.62% to 13,674.49. The S&P 500,... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Novocure (NVCR) Stock Down 30% Today?
Following Novocure’s disappointing late-stage clinical trial for its cancer-treating platform, NVCR stock stumbled on relevancy concerns. 
Via InvestorPlace
Why Is Cancer Focused-Novocure's Stock Plunging Today?
Novocure Ltd (NASDAQ: NVCR) shares are falling after the company's phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 clinical trial of Tumor Treating Fields (TTFields) together with paclitaxel in patients... 
Via Benzinga
Why NovoCure Stock Is Crashing Today
The company disappointed investors with its latest clinical trial update. 
Via The Motley Fool
Is NovoCure Stock a Buy Now?
There's nobody else angling for its market share, but that might not be enough. 
Via The Motley Fool
Why Novocure Was a Healthy Stock Today
The company stands to win big if its cancer-fighting technology does well in a late-stage clinical trial. 
Via The Motley Fool
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Rises; GD Culture Group Shares Spike Higher
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 150 points on Monday. The Dow traded up 0.46% to 34,505.54 while the NASDAQ rose 0.43% to 13,649.27. The S&P 500, also... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
Via Benzinga
US Stocks Open Higher; Kimco Realty To Acquire RPT Realty
U.S. stocks traded higher this morning, with the Dow Jones gaining over 250 points on Monday. Following the market opening Monday, the Dow traded up 0.81% to 34,626.22 while the NASDAQ rose 0.61% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
Novocure Plummets 34% After Its Cancer Treatment Fails In Ovarian Cancer
The company tested a regimen of chemotherapy and its tumor-treating fields. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Novocure Provides Update on Phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 Trial Evaluating Tumor Treating Fields Therapy in Platinum-resistant Ovarian Cancer
From Novocure
Via Business Wire
Could NovoCure Stock Help You Become a Millionaire?
The stock has some significant upside, but it also comes with considerable risks and volatility. 
Via The Motley Fool
Novocure to Participate in Upcoming Investor Conferences
From Novocure
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)
From The Law Offices of Frank R. Cruz
Via Business Wire
NOVOCURE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Calling All NovoCure Limited (NVCR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit
New York, New York - Attorney Advertising – Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action 
Via Law Firm Newswire
Topics Lawsuit
Exposures Financial Legal
NOVOCURE 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against NovoCure Limited - NVCR
From Kahn Swick & Foti, LLC
Via Business Wire
NVCR FINAL DEADLINE ALERT: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
NVCR DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against NovoCure Limited
From Bernstein Liebhard LLP
Via GlobeNewswire
NVCR FINAL DEADLINE FRIDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR
WHY: New York, NY - (NewMediaWire) - August 12, 2023 - New York, NY - (NewMediaWire) - August 12, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NovoCure... 
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
NVCR FINAL DEADLINE FRIDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DZS, TriplePoint, NovoCure, and UP Fintech and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
NASDAQ:NVCR Shareholder Notice: Lawsuit Alleges Securities Laws Violations by NovoCure Limited
San Diego, CA -- (SBWIRE) -- 08/09/2023 -- The Shareholders Foundation announced that an investor, who purchased shares of NovoCure Limited (NASDAQ:NVCR), filed a lawsuit over alleged violations of... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal
2 Incredibly Cheap Growth Stocks to Buy in August
These two innovative growth stocks appear deeply undervalued based on their long-term potential. 
Via The Motley Fool
Calling All NovoCure Limited (NVCR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit
New York, New York - Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action 
Via Law Firm Newswire
Topics Lawsuit
Exposures Financial Legal
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS